Evidence map›Paper›PMID 38260055›Full record

ArticleFrontiers in nephrology2023

Development and deployment of a nationwide predictive model for chronic kidney disease progression in diabetic patients.

Zhiyan Fu, Zhiyu Wang, Karen Clemente, Mohit Jaisinghani, Ken Mei Ting Poon, Anthony Wee Teo Yeo, Gia Lee Ang, Adrian Liew, Chee Kong Lim, Marjorie Wai Yin Foo and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Frontiers in nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Zhiyan FuIntegrated Health Information Systems (IHIS), Singapore, Singapore.
Zhiyu WangIntegrated Health Information Systems (IHIS), Singapore, Singapore.
Karen ClementeIntegrated Health Information Systems (IHIS), Singapore, Singapore.
Mohit JaisinghaniIntegrated Health Information Systems (IHIS), Singapore, Singapore.
Ken Mei Ting PoonIntegrated Health Information Systems (IHIS), Singapore, Singapore.
Anthony Wee Teo YeoIntegrated Health Information Systems (IHIS), Singapore, Singapore.
Gia Lee AngIntegrated Health Information Systems (IHIS), Singapore, Singapore.
Adrian LiewMount Elizabeth Novena Hospital, Singapore, Singapore.
Chee Kong LimNational Health Group Polyclinics, Singapore, Singapore.
Marjorie Wai Yin FooDepartment of Renal Medicine, Singapore General Hospital, Singapore, Singapore.
Wai Leng ChowEpidemiology and Disease Control Division, Ministry of Health, Singapore, Singapore.
Wee An TaIntegrated Health Information Systems (IHIS), Singapore, Singapore.
Ministry of Health · SGMount Elizabeth Novena Hospital · SGSingapore General Hospital · SGSingHealth Polyclinics · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Chronic kidney disease (CKD) is a major complication of diabetes and a significant disease burden on the healthcare system. The aim of this work was to apply a predictive model to identify high-risk patients in the early stages of CKD as a means to provide early intervention to avert or delay kidney function deterioration. Materials and methods: Using the data from the National Diabetes Database in Singapore, we applied a machine-learning algorithm to develop a predictive model for CKD progression in diabetic patients and to deploy the model nationwide. Results: Our model was rigorously validated. It outperformed existing models and clinician predictions. The area under the receiver operating characteristic curve (AUC) of our model is 0.88, with the 95% confidence interval being 0.87 to 0.89. In recognition of its higher and consistent accuracy and clinical usefulness, our CKD model became the first clinical model deployed nationwide in Singapore and has been incorporated into a national program to engage patients in long-term care plans in battling chronic diseases. The risk score generated by the model stratifies patients into three risk levels, which are embedded into the Diabetes Patient Dashboard for clinicians and care managers who can then allocate healthcare resources accordingly. Conclusion: This project provided a successful example of how an artificial intelligence (AI)-based model can be adopted to support clinical decision-making nationwide.

Indexed as

chronic kidney diseaseCKD progressiondiabeteskidney function deteriorationmachine learningprediction

Identifiers

PMID38260055
PMCPMC10800693
OpenAlexW4390665008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.